Trial intelligence / Profile preview

Tretinoin dosage before and after TCA peeling

NCT05004909Unknown

Start
Sep 2021
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of tretinoin in photoaging (2 arms). Primary endpoints: Change of Photoaged Skin Condition, Change of Subjective Pain Evaluation and 2 more. Status: unknown.

02

Drugs

tretinoin
03

Conditions

photoaging

Beyond the preview

Go deeper on NCT05004909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05004909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call